IL9 and neoplasm: In addition, the ectopically expressed membrane-bound form of IL-9 (MB-IL-9) has immune rejection and toxic effects on CT26 tumor cells and can magnify the cytotoxic effects of CD4+ T cells and CD8+ T cells [59].